Literature DB >> 7683169

Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).

J M Schröder1, R May, Y S Shin, M Sigmund, S Nase-Hüppmeier.   

Abstract

Polyglucosan body diseases in adults, contrary to infantile cases (Andersen's disease or type IV glycogenosis or amylopectinosis), are usually not associated with a significant deficiency of the branching enzyme (= amylo-1,4-1,6 transglucosidase). We, therefore, report on a 19-year-old male with complete branching enzyme deficiency presenting with severe myopathy, dilative cardiomyopathy, heart failure, dysmorphic features, and subclinical neuropathy. His 14-year-old brother had similar symptoms and was erroneously classified by a previous muscle biopsy as having central core disease but could later be identified as also having polyglucosan body myopathy. The skeletal muscle, endomyocardiac, and sural nerve biopsies as well as the autopsy revealed extraordinarily severe deposits of polyglucosan bodies not only in striated and smooth muscle fibers, but also in histiocytes, fibroblasts, perineurial cells, axons and astrocytes. Occasional paracrystalline mitochondrial inclusions were also noted. Thus, this patient represents to our knowledge the first juvenile, familial case of polyglucosan body disease with total branching enzyme deficiency and extensive polyglucosan body storage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683169     DOI: 10.1007/bf00334454

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  46 in total

1.  Type IV glycogenosis. Report of a case proven by characterization of glycogen and studied at necropsy.

Authors:  J B SIDBURY; J MASON; W B BURNS; B H RUEBNER
Journal:  Bull Johns Hopkins Hosp       Date:  1962-09

2.  A MYOPATHY PRESENTING IN ADULT LIFE WITH FEATURES SUGGESTIVE OF GLYCOGEN STORAGE DISEASE.

Authors:  J M Holmes; C R Houghton; A L Woolf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-11       Impact factor: 10.154

3.  Immunological homogeneity of Lafora body, corpora amylacea, basophilic degeneration in heart, and intracytoplasmic inclusions of liver and heart in type IV glycogenosis.

Authors:  T Yokota; T Ishihara; H Kawano; Y Yamashita; M Takahashi; F Uchino; T Kamei; Y Kusunose; M Yamada; N Matsumoto
Journal:  Acta Pathol Jpn       Date:  1987-06

4.  Glycogenosis with amylopectinoid deposits in a 13-year-old girl.

Authors:  T Tuñón; O Bengoechea; J Narbona
Journal:  Clin Neuropathol       Date:  1988 May-Jun       Impact factor: 1.368

5.  Myopathy with tremor and dementia: a metabolic disorder? Case report with postmortem study.

Authors:  A Torvik; P Dietrichson; H Svaar; P Hudgson
Journal:  J Neurol Sci       Date:  1974-02       Impact factor: 3.181

6.  Glycogenosis. IV. A new cause of infantile hypotonia.

Authors:  H Zellweger; S Mueller; V Ionasescu; S S Schochet; W F McCormick
Journal:  J Pediatr       Date:  1972-05       Impact factor: 4.406

7.  The fine structure of glycogen from type IV glycogen-storage disease.

Authors:  C Mercier; W J Whelan
Journal:  Eur J Biochem       Date:  1970-11

8.  Type IV glycogen storage disease: branching enzyme deficiency in skin fibroblasts and possible heterozygote detection.

Authors:  R R Howell; M M Kaback; B I Brown
Journal:  J Pediatr       Date:  1971-04       Impact factor: 4.406

9.  Branching enzyme in erythrocytes. Detection of type IV glycogenosis homozygotes and heterozygotes.

Authors:  Y S Shin; H Steigüber; P Klemm; W Endres; O Schwab; G Wolff
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

Review 10.  Glycogen metabolism and glycogen-storage diseases.

Authors:  F Huijing
Journal:  Physiol Rev       Date:  1975-10       Impact factor: 37.312

View more
  18 in total

Review 1.  Neuropathology of Charcot-Marie-Tooth and related disorders.

Authors:  J Michael Schröder
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

2.  Severe neonatal onset of glycogenosis type IV: clinical and laboratory findings leading to diagnosis in two siblings.

Authors:  B Giuffrè; R Parini; T Rizzuti; L Morandi; O P van Diggelen; C Bruno; M Giuffrè; G Corsello; F Mosca
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 3.  Frontotemporal dementia: a bridge between dementia and neuromuscular disease.

Authors:  Adeline S L Ng; Rosa Rademakers; Bruce L Miller
Journal:  Ann N Y Acad Sci       Date:  2014-12-30       Impact factor: 5.691

4.  Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings.

Authors:  Fanny Mochel; Raphael Schiffmann; Marjan E Steenweg; Hasan O Akman; Mary Wallace; Frédéric Sedel; Pascal Laforêt; Richard Levy; J Michael Powers; Sophie Demeret; Thierry Maisonobe; Roseline Froissart; Bruno Barcelos Da Nobrega; Brent L Fogel; Marvin R Natowicz; Catherine Lubetzki; Alexandra Durr; Alexis Brice; Hanna Rosenmann; Varda Barash; Or Kakhlon; J Moshe Gomori; Marjo S van der Knaap; Alexander Lossos
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

5.  Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease.

Authors:  A McConkie-Rosell; C Wilson; D A Piccoli; J Boyle; T DeClue; P Kishnani; J J Shen; A Boney; B Brown; Y T Chen
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

6.  Neonatal hypotonia and cardiomyopathy secondary to type IV glycogenosis.

Authors:  T T Tang; A D Segura; Y T Chen; L M Ricci; R A Franciosi; M L Splaingard; M S Lubinsky
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Uncommon types of polyglucosan bodies in the human brain: distribution and relation to disease.

Authors:  H Sugiyama; J A Hainfellner; H Lassmann; S Indravasu; H Budka
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 8.  Glycogen storage diseases: new perspectives.

Authors:  Hasan Ozen
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

9.  Multisystem involvement in a patient due to accumulation of amylopectin-like material with diminished branching enzyme activity.

Authors:  T F Eminoglu; L Tumer; I Okur; R Olgunturk; A Hasanoglu; I I Gonul; B Dalgic
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

10.  Branching enzyme deficiency: expanding the clinical spectrum.

Authors:  Carmen Paradas; Hasan O Akman; Carolina Ionete; Heather Lau; Peter N Riskind; David E Jones; Thomas W Smith; Michio Hirano; Salvatore Dimauro
Journal:  JAMA Neurol       Date:  2014-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.